EphA2 siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemEphA2 siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-29304
Gene NameEPH receptor A2
Quantity10 µM
Specieshuman
NCBI Full Gene NameEPH receptor A2
NCBI Gene AliasesARCC2, CTPA, CTPP1, CTRCT6, ECK
TypesiRNA/dsRNA

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Activation of EphA2-EGFR signaling in oral epithelial cells by Candida albicans virulence factorsPLoS pathogensJanuary 1, 2021Swidergall M, Solis NV, Millet N, Huang MY, Lin J, Phan QT, Lazarus MD, Wang Z, Yeaman MR, Mitchell AP, et al.plates and transfected with 80 pmol EGFR siRNA (sc-29301, Santa Cruz Biotechnology), and EphA2 siRNA (sc-29304, Santa Cruz Biotechnology), or a similar amount of random control siRNA (sc-37007, Santa Cruz Biotechnology)

(2) Role of EphA2-PI3K signaling in vasculogenic mimicry induced by cancer-associated fibroblasts in gastric cancer cellsOncology lettersSeptember 1, 2019Kim HS, Won YJ, Shim JH, Kim HJ, Kim BS, Hong HN.

(3) Morphological characteristics of vasculogenic mimicry and its correlation with EphA2 expression in gastric adenocarcinomaScientific reportsMarch 4, 2019Kim HS, Won YJ, Shim JH, Kim HJ, Kim J, Hong HN, Kim BS.reported as mean ± SD. EphA2 gene knockdown using siRNA siRNA for EphA2 was obtained from Santa Cruz (sc-29304; Santa Cruz Biotechnology, CA, USA). The target sequence was 5′-AATGACATGCCGATCTACATG-3′ (EphA2)43,

(4) Cancer-associated fibroblasts promote gastric tumorigenesis through EphA2 activation in a ligand-independent mannerJournal of cancer research and clinical oncologySeptember 1, 2018Hong HN, Won YJ, Shim JH, Kim HJ, Han SH, Kim BS, Kim HS.

(5) EphA2 is an epithelial cell pattern recognition receptor for fungal β-glucansNature microbiologyJanuary 1, 2018Swidergall M, Solis NV, Lionakis MS, Filler SG.with random control siRNA (Santa Cruz Biotechnology; sc-37007), EphA2 siRNA (Santa Cruz Biotechnology; sc-29304), or EphB2 siRNA (Santa Cruz Biotechnology; sc-39949) with Lipofectamine 2000 (Invitrogen) following

(6) Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cellsJournal of hematology & oncologyOctober 6, 2017Megiorni F, Gravina GL, Camero S, Ceccarelli S, Del Fattore A, Desiderio V, Papaccio F, McDowell HP, Shukla R, Pizzuti A, et al.× 105 cells/well in 6-well plates; small interfering RNA (siRNA) against human EPH-A2 (EPH-A2siRNA, sc-29304 by Santa Cruz Biotechnology, Dallas, TX) and/or EPH-A2 (EPH-B2siRNA, sc-39949 by Santa Cruz Biotechnology)

(7) Male hormones activate EphA2 to facilitate Kaposi's sarcoma-associated herpesvirus infection: Implications for gender disparity in Kaposi's sarcomaPLoS pathogensSeptember 1, 2017Wang X, Zou Z, Deng Z, Liang D, Zhou X, Sun R, Lan K.conjugate)-A (sc-36869, Santa Cruz Biotechnology), AR siRNA (sc-29204, Santa Cruz Biotechnology), EphA2 siRNA (sc-29304, Santa Cruz Biotechnology), and RSK1 siRNA (6309S, Cell Signaling Technology); Lipofectamine 2000 (11668019,

(8) EphA2 is a functional receptor for the growth factor progranulinThe Journal of cell biologyDecember 5, 2016Neill T, Buraschi S, Goyal A, Sharpe C, Natkanski E, Schaefer L, Morrione A, Iozzo RV.sense and antisense) directed against different regions of Homo sapiens EPHA2, SORT1, or GRN mRNAs (sc-29304, sc-42119, and sc-39261, respectively; Santa Cruz Biotechnologies, Inc.). Sequences for the targeting

(9) Prognostic significance of combinations of RNA-dependent protein kinase and EphA2 biomarkers for NSCLCJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerMarch 1, 2013Guo C, Shao R, Correa AM, Behrens C, Johnson FM, Raso MG, Prudkin L, Solis LM, Nunez MI, Fang B, et al.

(10) EphA2 silencing in nasopharyngeal carcinoma leads to decreased proliferation, invasion and increased sensitization to paclitaxelOncology lettersSeptember 1, 2012Tan P, Liu Y, Yu C, Su Z, Li G, Zhou X, Huang D, Zhang X, Qiu Y, Tian Y.

(11) Downregulation of EphA2 expression suppresses the growth and metastasis in squamous-cell carcinoma of the head and neck in vitro and in vivoJournal of cancer research and clinical oncologyFebruary 1, 2012Liu Y, Yu C, Qiu Y, Huang D, Zhou X, Zhang X, Tian Y.

(12) EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activationThe Journal of biological chemistryJune 11, 2010Faoro L, Singleton PA, Cervantes GM, Lennon FE, Choong NW, Kanteti R, Ferguson BD, Husain AN, Tretiakova MS, Ramnath N, et al.

(13) Role of tyrosine phosphatase SHP-1 in the mechanism of endorepellin angiostatic activityBloodNovember 26, 2009Nyström A, Shaik ZP, Gullberg D, Krieg T, Eckes B, Zent R, Pozzi A, Iozzo RV.

(14) RNA interference targeting EphA2 inhibits proliferation, induces apoptosis, and cooperates with cytotoxic drugs in human glioma cellsSurgical neurologyDecember 1, 2008Zhou Z, Yuan X, Li Z, Tu H, Li D, Qing J, Wang H, Zhang L.

(15) Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cellsCancerNovember 15, 2006Nasreen N, Mohammed KA, Antony VB.

Be the First to Write a Review!

EphA2 siRNA (h)

EphA2 siRNA (h) from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (15)

Reviews

EphA2 siRNA (h) from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map